Skip to main content

Advertisement

Log in

Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Surfactant protein D (SP-D) belongs to the collectin family and has pro-and anti-inflammatory capacities depending on its oligomerization. Previously, circulating SP-D was shown to be decreased in early rheumatoid arthritis (RA) and negatively correlated to disease activity. This study aimed at assessing the diurnal rhythmicity and the influence of physical activity on circulating SP-D in patients with RA at different stages compared with healthy individuals. Patients with early RA (ERA) with disease duration <6 months and with long-standing RA (LRA) with disease duration 5–15 years were included in two sub-studies. Healthy individuals served as controls. Diurnal variation: blood samples were collected every 3 h from 7 a.m to 10 p.m and the following morning. Physical activity: blood sampling was done before and after standardized physical challenge. SP-D was measured by ELISA. SP-D exhibited diurnal variation in healthy controls (n = 15) and in patients with ERA (n = 9) and LRA (n = 9) with peak values at 10 a.m. and nadir in the evening (controls: P < 0.001, ERA: P = 0.004 and LRA: P = 0.009). Three hours after cessation of physical activity, SP-D decreased below pre-exercise levels in both ERA (n = 10), LRA (n = 10) and controls (n = 13) (ERA: P < 0.001, LRA: P < 0.001 and controls: P = 0.005). In patients with RA, the decline was already observed 1 h post-exercise. Circulating SP-D exhibits diurnal variation both in patients with RA at different stages and in healthy controls. SP-D in serum decreases following physical activity in health and RA disease. This study underscores the need of standardized blood sampling conditions in future studies on SP-D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Holmskov U (2000) Collectins and collectin receptors in innate immunity. APMIS Suppl 100:1–59

    PubMed  CAS  Google Scholar 

  2. Leth-Larsen R, Garred P, Jensenius H et al (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 174:1532–1538

    PubMed  CAS  Google Scholar 

  3. Hartshorn KL, White MR, Tecle T et al (2007) Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res 8:9

    Article  PubMed  Google Scholar 

  4. Hartshorn KL, Crouch E, White MR et al (1998) Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol Lung Cell Mol Physiol 274:L958–L969

    CAS  Google Scholar 

  5. Bufler P, Schmidt B, Schikor D et al (2003) Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol 28:249–256

    Article  PubMed  CAS  Google Scholar 

  6. Stahlman MT, Gray ME, Hull WM et al (2002) Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 50:651–660

    Article  PubMed  CAS  Google Scholar 

  7. Crouch E, Parghi D, Kuan SF et al (1992) Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Physiol 263:L60–L66

    PubMed  CAS  Google Scholar 

  8. Voorhout WF, Veenendaal T, Kuroki Y et al (1992) Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 40:1589–1597

    Article  PubMed  CAS  Google Scholar 

  9. Leth-Larsen R, Nordenbaek C, Tornoe I et al (2003) Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol 108:29–37

    Article  PubMed  CAS  Google Scholar 

  10. Nagae H, Takahashi H, Kuroki Y et al (1997) Enzyme-linked immunosorbent assay using F(ab’)2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta 266:157–171

    Article  PubMed  CAS  Google Scholar 

  11. Sorensen GL, Madsen J, Kejling K et al (2006) Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 290:H2286–H2294

    Article  PubMed  CAS  Google Scholar 

  12. Woodsworth BA, Lathers D, Neal JG et al (2006) Immunolocalization of surfactant protein A and D in sinonasal mucosa. Am J Rhinol 20:461–465

    Article  Google Scholar 

  13. Oberley RE, Goss KL, Dahmoush L et al (2005) A role for surfactant protein D in innate immunity of the human prostate. Prostate 65:241–251

    Article  PubMed  CAS  Google Scholar 

  14. Ni M, Evans DJ, Hawgood S et al (2005) Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun 73:2147–2156

    Article  PubMed  CAS  Google Scholar 

  15. Leth-Larsen R, Floridon C, Nielsen O et al (2004) Surfactant protein D in the female genital tract. Mol Hum Reprod 10:149–154

    Article  PubMed  CAS  Google Scholar 

  16. Madsen J, Kliem A, Tornoe I et al (2000) Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 164:5866–5870

    PubMed  CAS  Google Scholar 

  17. Hermans CEDR, Bernard ALFR (1999) Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med 159:646–678

    PubMed  CAS  Google Scholar 

  18. Christensen AF, Holmskov U, Sorensen GL et al (2008) Surfactant protein D is decreased in rheumatoid arthritis. Arthritis Rheum 58:S708

    Google Scholar 

  19. Hoegh SV, Lindegaard HM, Sorensen GL et al (2008) Circulating surfactant protein D is decreased in early rheumatoid arthritis: A 1-year prospective study. Scand J Immunol 67:71–76

    Article  PubMed  CAS  Google Scholar 

  20. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  21. Thorsen H, Hansen TM, Mckenna SP et al (2001) Adaption into Danish of the stanford health assessment questionnaire (HAQ) and the rheumatoid arthritis quality of life scale (RaQol). Scand J Rheumatol 30:103–109

    Article  PubMed  CAS  Google Scholar 

  22. van Riel PL, Scott DL (2004) Eular handbook of clinical assessments in rheumatoid arthritis, 3 edn. Van Zuiden Communications B.V., CC Alphen aan den Rijn, The Netherlands

  23. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn Stockh 18:481–491

    PubMed  CAS  Google Scholar 

  24. Høier-Madsen M, Nielsen LP, Møller S (1986) Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr Laeger 148:2018–2021

    PubMed  Google Scholar 

  25. Hoegh SV, Sorensen GL, Tornoe I et al (2009) Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology (Epub ahead of print)

  26. Sorensen GL, Husby S, Holmskov U (2007) Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212:381–416

    Article  PubMed  CAS  Google Scholar 

  27. Haczku A, Cao Y, Vass G et al (2006) IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol 176:3557–3565

    PubMed  CAS  Google Scholar 

  28. Ikegami M, Whitsett JA, Chroneos ZC et al (2000) IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol 278:L75–L80

    PubMed  CAS  Google Scholar 

  29. Snyder GD, Oberley-Deegan RE, Goss KL et al (2008) Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 91529

  30. Dulkerian SJ, Gonzales LW, Ning Y et al (1996) Regulation of surfactant proetin D in human fetal lung. Am J Respir Cell Mol Biol 15:781–786

    PubMed  CAS  Google Scholar 

  31. Wang JY, Yeh TF, Lin YC et al (1996) Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 51:907–913

    Article  PubMed  CAS  Google Scholar 

  32. Fernandez-Real JM, Valdes S, Manco M et al (2010) Surfactant protein D, a marker of lung innate immunity, is positively associated with insulin resistance. Diabetes Care. doi:dc09-0542/DC1 (E-pub ahead of print)

  33. Cutolo M, Straub RH (2008) Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun Rev 7:223–228

    Article  PubMed  CAS  Google Scholar 

  34. Petrovsky N, McNair P, Harrison LC (1998) Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10:307–312

    Article  PubMed  CAS  Google Scholar 

  35. Cutolo M, Maestroni GJ, Otsa K et al (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216

    Article  PubMed  CAS  Google Scholar 

  36. Maestroni GJ, Sulli A, Pizzorni C et al (2002) Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966:271–275

    Article  PubMed  CAS  Google Scholar 

  37. Zoli A, Lizzio MM, Ferlisi EM et al (2002) ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 21:289–293

    Article  PubMed  CAS  Google Scholar 

  38. Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis. Implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399–408

    Article  PubMed  Google Scholar 

  39. Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration and adaptation. Physiol Rev 80:1055–1081

    PubMed  CAS  Google Scholar 

  40. Hill EE, Zack E, Battaglini C et al (2008) Exercise and circulating cortisol level: the intensity threshold effect. J Endocrinol Invest 31:587–591

    PubMed  CAS  Google Scholar 

  41. Chikanza IC, Petrou P, Kingsley G et al (1992) Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:1281–1288

    PubMed  CAS  Google Scholar 

  42. Eijsbouts AM, van den Hoogen FH, Laan RF et al (2005) Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 23:658–664

    PubMed  CAS  Google Scholar 

  43. Pool AJ, Whipp BJ, Skasick AJ et al (2004) Serum cortisol reduction and abnormal prolactin and CD4 +/CD8 + T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology 43:43–48

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Danish Rheumatism Association and the A. P Møller Foundation for the Advancement of Medical Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. F. Christensen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christensen, A.F., Hoegh, S.V., Lottenburger, T. et al. Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis. Rheumatol Int 31, 1617–1623 (2011). https://doi.org/10.1007/s00296-010-1538-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1538-7

Keywords

Navigation